Malaria Ag Rapid Testing Market Size

  • Report ID: 5547
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Malaria Ag Rapid Testing Market size was over USD 36.93 billion in 2024 and is projected to reach USD 67.93 billion by 2037, growing at around 4.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of malaria ag rapid testing is assessed at USD 38.44 billion.

This market is poised to rise on account of the growing prevalence of malaria. According to the World Health Organization, in comparison to 244 million cases in 2021, there were a total of 249 million cases of malaria in 2022, according to the most recent World Malaria Report. The predicted number of malaria deaths stood to 608 000 in 2022 compared to 610 000 in 2021. Hence, the market demand for malaria ag rapid testing is poised to rise.

Furthermore, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae are the four different types of malaria parasites that affect humans. However, it is estimated that more different types of malaria are set to become prevalent in the coming years. Therefore, the need for malaria ag rapid testing is poised to surge in the coming years.  


Malaria Ag Rapid Testing Market share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of malaria ag rapid testing is assessed at USD 38.44 billion.

The malaria ag rapid testing market size was over USD 36.93 billion in 2024 and is projected to reach USD 67.93 billion by 2037, growing at around 4.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in adoption of latest technology, rise in government initiatives for the awareness regarding malaria, and extreme weather event to increase prevalence of malaria.

North America industry is predicted to account for largest revenue share of 30% by 2037, due to rising travelers returning to North America.

The major players in the market are Wyss Institute, Novartis AG, Alere, Inc., Nectar Lifesciences Ltd., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos